Anticipated and Perceived Benefits Following Hepatitis C Treatment
| Status: | Completed |
|---|---|
| Conditions: | Hepatitis, Hepatitis, Hepatitis |
| Therapuetic Areas: | Immunology / Infectious Diseases |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 10/26/2018 |
| Start Date: | October 2016 |
| End Date: | July 2018 |
A Qualitative and Quantitative Evaluation of Patients' Anticipated and Perceived Treatment Benefits Following HCV Viral Eradication
The study is both qualitative and quantitative, gathering patient's perceptions of HCV
treatment benefits before and after HCV treatment by administering surveys and conducting
in-depth qualitative patient interviews. The study seeks to understand all anticipated and
actual benefits patients perceive before and after viral eradication.
treatment benefits before and after HCV treatment by administering surveys and conducting
in-depth qualitative patient interviews. The study seeks to understand all anticipated and
actual benefits patients perceive before and after viral eradication.
This study employs a mixed methods (qualitative and quantitative) pre-post study design
utilizing in-depth qualitative interviews and patient reported outcome surveys. Pre-treatment
surveys and interviews will be conducted before HCV therapy commences to understand all
potential psychological, social, physical and medical consequences perceived to be related to
HCV and the patients' anticipation (hope for) of improvements in these factors after viral
eradication. Post-treatment surveys and interviews will occur 4 to 8 months after treatment
ends to examine long-term treatment benefits, i.e., changes in HCV-related factors, such as
symptoms, functioning, and health status.
utilizing in-depth qualitative interviews and patient reported outcome surveys. Pre-treatment
surveys and interviews will be conducted before HCV therapy commences to understand all
potential psychological, social, physical and medical consequences perceived to be related to
HCV and the patients' anticipation (hope for) of improvements in these factors after viral
eradication. Post-treatment surveys and interviews will occur 4 to 8 months after treatment
ends to examine long-term treatment benefits, i.e., changes in HCV-related factors, such as
symptoms, functioning, and health status.
Inclusion Criteria:
- Age 21 or older
- English-speaking
- Any genotype
- Any treatment duration (e.g. 8, 12, or 24 weeks)
- Has been written a prescription for a sofosbuvir (SOF)-containing regimen.
Exclusion Criteria:
- Currently listed for liver transplant; post-liver transplant
We found this trial at
1
site
Univ of North Carolina Carolina’s vibrant people and programs attest to the University’s long-standing place...
Click here to add this to my saved trials
